Repair Absolute - Base

Hazard statements (CLP)

H315, H317, H319, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)]

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Skin corrosion/irritation, Category 2 Skin sensitisation, Category 1 H315 H317 Serious eye damage/eye irritation, Category 2 Hazardous to the aquatic environment – Chronic Hazard, H319 H411 Skin sensitisation, Category 1 Category 2 H317 Hazardous to the aquatic environment – Chronic Hazard, Full text of H- and EUH-statements: see section 16 H411 Category 2 Full text of H- and EUH-statements: Adverse physicochemical, see section 16 human health and environmental effects Adverse physicochemical, human health and environmental effects Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : Hazard pictograms (CLP)

Adverse physicochemical, human health and environmental effects

Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects

Hazard pictograms

GHS07 GHS09

Signal word

Warning Warning Ether

Contains

GHS07 GHS09 bis-[4-(2,3-epoxipropoxi)phenyl]propane; Phenol-Formaldehyde Polymer; Alkyl Glycidyl

Hazard statements

bis-[4-(2,3-epoxipropoxi)phenyl]propane; Phenol-Formaldehyde Polymer; Alkyl Glycidyl H315 - Causes skin irritation. Ether H317 - May cause an allergic skin reaction. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H317 - May cause an allergic skin reaction. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

H319 - Causes serious eye irritation. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. H411 - Toxic to aquatic life with long lasting effects. P264 - Wash hands, forearms and face thoroughly after handling. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing P264 - Wash hands, forearms and face thoroughly after handling. protection. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing 8/30/2024 (Revision date) protection. GB - en 1/14 Revision: 3.0 8/30/2024 (Revision date) GB - en 1/14 P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P391 - Collect spillage.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH 4-Nonylphenol (84852-15-3) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH 4-Nonylphenol (84852-15-3) regulation, in accordance with Annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) included in the list established in 4-Nonylphenol (84852-15-3) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Substance(s) not included in the list established in bis-[4-(2,3-epoxipropoxi)phenyl]propane (1675-54-3) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605